Stocks and Investing Stocks and Investing
Mon, November 6, 2023
Sun, November 5, 2023
Fri, November 3, 2023

Luca Issi Maintained (ALNY) at Buy with Decreased Target to $230 on, Nov 3rd, 2023


Published on 2024-10-28 07:20:48 - WOPRAI, Luca Issi
  Print publication without navigation


Luca Issi of RBC Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $235 to $230 on, Nov 3rd, 2023.

Luca has made no other calls on ALNY in the last 4 months.



There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $170 on, Monday, October 16th, 2023
  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, October 11th, 2023


These are the ratings of the 7 analyists that currently disagree with Luca


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $395 on, Wednesday, October 11th, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
  • Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
Contributing Sources